Gui Yang

1.3k total citations · 1 hit paper
19 papers, 629 citations indexed

About

Gui Yang is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Gui Yang has authored 19 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Gui Yang's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Immune cells in cancer (3 papers). Gui Yang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Immune cells in cancer (3 papers). Gui Yang collaborates with scholars based in China, Hong Kong and Russia. Gui Yang's co-authors include Yunbao Pan, Junli Fan, Yueting Tang, Shuang Guo, Yirong Li, Xinran Li, Yinjuan Liu, Xue Han, Hanning Hu and Xinghua Long and has published in prestigious journals such as International Journal of Obesity, Clinical Microbiology and Infection and Frontiers in Pharmacology.

In The Last Decade

Gui Yang

17 papers receiving 621 citations

Hit Papers

Berberine ameliorates DSS-induced intestinal mucosal barr... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui Yang China 11 343 166 89 67 57 19 629
Ruochen Zang China 9 557 1.6× 292 1.8× 51 0.6× 33 0.5× 118 2.1× 13 926
Zhaolong Cao China 5 517 1.5× 151 0.9× 29 0.3× 34 0.5× 229 4.0× 8 854
Huihui Wang China 11 364 1.1× 315 1.9× 97 1.1× 30 0.4× 59 1.0× 32 787
Yunlong Li China 16 145 0.4× 254 1.5× 57 0.6× 15 0.2× 20 0.4× 85 791
Zhaowei Yang China 17 188 0.5× 323 1.9× 26 0.3× 18 0.3× 58 1.0× 34 840
Xiaowei Wu China 10 333 1.0× 142 0.9× 17 0.2× 40 0.6× 47 0.8× 17 563
María Florencia Gómez Castro Argentina 6 533 1.6× 167 1.0× 46 0.5× 44 0.7× 118 2.1× 8 814
Lianzi Wang China 12 304 0.9× 317 1.9× 52 0.6× 27 0.4× 52 0.9× 21 748

Countries citing papers authored by Gui Yang

Since Specialization
Citations

This map shows the geographic impact of Gui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Yang more than expected).

Fields of papers citing papers by Gui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Yang. The network helps show where Gui Yang may publish in the future.

Co-authorship network of co-authors of Gui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Gui Yang. A scholar is included among the top collaborators of Gui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui Yang. Gui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dong, Yifeng, Xiwen Zhang, Jiang‐Qi Liu, et al.. (2025). Modulation of Mettl5 alleviates airway allergy by regulating the epigenetic profile of M2 macrophages. Cellular Signalling. 131. 111740–111740.
2.
4.
Gao, Fei, Feng Zhu, Bo Shuai, et al.. (2024). Quercetin ameliorates ulcerative colitis by restoring the balance of M2/M1 and repairing the intestinal barrier via downregulating cGAS‒STING pathway. Frontiers in Pharmacology. 15. 1351538–1351538. 22 indexed citations
5.
Zhang, Xiwen, Yifeng Dong, Hanqing Zhang, et al.. (2024). Dust mite antigens endow dendritic cells with the capacity to induce a Th2 response by regulating their methylation profiles. Cell Communication and Signaling. 22(1). 606–606. 1 indexed citations
6.
Li, Mingyue, Weina Guo, Yalan Dong, et al.. (2022). Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice. Genomics Proteomics & Bioinformatics. 20(2). 288–303. 37 indexed citations
7.
Tang, Yueting, Fen Yao, Gui Yang, et al.. (2022). Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown. BMC Infectious Diseases. 22(1). 10–10. 1 indexed citations
8.
Dong, Yalan, Heng Fan, Zhe Zhang, et al.. (2022). Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. International Journal of Biological Sciences. 18(4). 1381–1397. 116 indexed citations breakdown →
9.
Tian, Chunxia, Feng Jiang, Yalan Dong, et al.. (2022). Berberine plays a cardioprotective role by inhibiting macrophage Wnt5a/β‐catenin pathway in the myocardium of mice after myocardial infarction. Phytotherapy Research. 37(1). 50–61. 23 indexed citations
10.
Tang, Yueting, Huaqin Pan, Fen Yao, et al.. (2021). Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. Cytokine. 143. 155523–155523. 23 indexed citations
11.
Yang, Gui, et al.. (2021). Livin in synergy with Ras induces and sustains corticosteroid resistance in the airway mucosa. International Journal of Biological Sciences. 17(8). 2089–2098. 8 indexed citations
12.
Deng, Qiaoling, Guangming Ye, Yunbao Pan, et al.. (2021). High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study. Frontiers in Medicine. 8. 676560–676560. 10 indexed citations
13.
Pan, Yunbao, Xinran Li, Gui Yang, et al.. (2020). Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign. Clinical Microbiology and Infection. 27(2). 253–257. 21 indexed citations
14.
Kang, Zhenyu, Shanshan Luo, Gui Yang, et al.. (2020). Obesity is a potential risk factor contributing to clinical manifestations of COVID-19. International Journal of Obesity. 44(12). 2479–2485. 42 indexed citations
15.
Pan, Yunbao, Xinran Li, Gui Yang, et al.. (2020). Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. Journal of Infection. 81(1). e28–e32. 255 indexed citations
16.
Dong, Yalan, Haifeng Zhou, Mingyue Li, et al.. (2020). A novel simple scoring model for predicting severity of patients with SARS‐CoV‐2 infection. Transboundary and Emerging Diseases. 67(6). 2823–2829. 45 indexed citations
17.
Zhou, Haifeng, Zili Zhang, Heng Fan, et al.. (2020). Urinalysis, but not Blood Biochemistry, Detects the Early Renal-Impairment in Patients with COVID-19. SSRN Electronic Journal. 4 indexed citations
18.
Wu, Yongjin, Xianhai Zeng, Lijuan Song, et al.. (2018). B cell lymphoma‐2‐like protein‐12 association with T‐helper 2 inflammation in chronic rhinosinusitis with allergy. International Forum of Allergy & Rhinology. 8(11). 1300–1307. 3 indexed citations
19.
Liu, Jun, Fenghong Chen, Shuqi Qiu, et al.. (2016). Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients.. PubMed. 8(12). 5256–5270. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026